SMART Trial for Buprenorphine-Naloxone Medication Assisted Treatment Adherence
Key facts
- Who runs it
- Karen Derefinko, PhD
- Where
- Memphis, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 332 people enrolled
- Started
- 1 Feb 2022
- Ended
- 1 Feb 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Contingency Management
- Brief Motivational Interviewing + Substance Free Activities + Mindfulness
- Record updated
- 25 February 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Present with symptoms of Opioid Use Disorder
- Eligible of receipt of buprenorphine-naloxone medication as determined by Study Doctor
- Access to a telephone
Who cannot take part
- Under 18 years old
- Unable to understand spoken English
Where in United States
- University of Tennessee Health Science CenterMemphis, United States
About the trial
What the trial wants to find out
The purpose of this study is to compare the effectiveness of two different interventions for medication-assisted treatment (MAT) adherence: Contingency Management (CM) and Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BSM).
The 3 groups in the trial
- Contingency Management (CM)Existing treatment, for comparison
CM is a behavioral method that employs external rewards for target behavior. Participants will receive gift cards for adhering to treatment (attending physician visits and being adherent to buprenorphine-naloxone) for their first 4 clinic visits.
Treatment: Contingency Management
- Brief Motivational Interviewing + Substance Free Activities + Mindfulness (BSM)Existing treatment, for comparison
Participants will receive the BSM intervention at 4 timepoints.
Treatment: Brief Motivational Interviewing + Substance Free Activities + Mindfulness
- BSM+CMExisting treatment, for comparison
BSM+CM is a combination of the two other arms. Participants may be randomized to this arm only in stage 2 of the SMART design.
Treatment: Contingency Management and Brief Motivational Interviewing + Substance Free Activities + Mindfulness
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Testing the Effects of Contingency Management and Behavioral Economics on Buprenorphine-Naloxone Treatment Adherence Using a Sequential Multiple Assignment Randomized Trial (SMART) Design
- Publications
- Record updated
- 25 February 2025